Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AR✓SelectedUSD · ARGSK vs AR performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs AR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+76.8%
AR return
+45.1%
Excess return
+31.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioARExcessAlpha
1D-2.7%-0.8%-1.9%-2.7%
7D-4.2%-1.8%-2.4%-4.1%
30D-7.5%+12.6%-20.1%-7.9%
3M-3.3%+10.0%-13.3%-3.6%
6M-9.3%+0.6%-10.0%-9.4%
YTD+1.6%+13.4%-11.8%+1.0%
1Y+25.5%+21.7%+3.8%+24.4%
3Y+49.3%+45.8%+3.4%+46.0%
5Y+46.7%+144.3%-97.6%+39.5%
10Y+76.8%+41.8%+35.0%+75.9%
All+76.8%+45.1%+31.7%+75.9%

Cumulative growth

Daily Returns

Daily percentage return beside AR.

Daily Out/Under-Performance

Portfolio return minus AR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded AR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling